Ajanta Pharma: Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | Value Research

Ajanta Pharma: Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on September 14 2022 for Ravi Agrawal Trustee Ravi Agrawal Trust

Click here to view PDF


Other Categories